For anyone who has battled breast cancer, the threat of recurring tumors is one that no treatment can completely eliminate—yet. But with Mamma-Print, a genetic test of a tumor's DNA, patients and doctors can get a better handle on how likely it is that the cancer will spread. The 70-gene screen, developed by Amsterdam-based Agendia, is the first test approved by the FDA that measures the activity of genes at work.
Available Approved in February
agendia.com
What was the most revolutionary gadget that you just can't live without? Browse through the nominees and make your vote
The iPhone is more than just a gadget. It's a genuine handheld computer, the first device that really deserves the name
Lev Grossman discusses the process of choosing the Best Inventions of the Year
All the details on the newest products to help you decide how to spend your money wisely
A research team at Philips has developed clothes that look good and let others know how you feel
NASA, Boeing and the U.S. Air Force are teaming up to develop a Blended-Wing Body aircraft for the military
From Leonardo DaVinci to the YouTube gurus, read about how these inventors changed our lives
Scientists in Hong Kong have discovered there's a better way to build a bra. How will the lingerie industry respond? An open letter to the one man who can help
Afterbirth for Dinner
The Battle Over Michael Jackson's Legacy
Canada Spends Big to Save GM, So Why Not Mexico?
Photos: U.S. Marines Open a New Offensive in Afghanistan
The Incredible Shrinking Sheep of Scotland
In Peru Sports, Men Bumble, And Women Shine
Photos: The Real-Life John Dillinger
Photos: India's Contraband Wildlife
Photos: Sacha Baron Cohen's Outrageous Brüno Promotions
The Recession Hits Summer Camp